Overview

Tessa Therapeutics is a clinical-stage biotechnology company developing a portfolio of novel next-generation cell therapies for cancer.

Tessa is leading the way in CD30 targeting using cell therapy. CD30 is well validated lymphoma target with homogenous expression in Classical Hodgkin Lymphoma and multiple subsets of non-Hodgkin Lymphomas. Tessa’s approach to target CD30-positive cancers using CAR-T (Chimeric Antigen Receptor) cells has demonstrated excellent safety and efficacy in early clinical trials. Having received the RMAT and PRIME designation, Tessa is now advancing the therapy to a pivotal trial.

Off-the-shelf, allogeneic cell therapy has significant advantages and is the next frontier in cancer treatment. Tessa is developing a unique and potentially transformational allogeneic CD30-CAR EBVST platform capable of targeting a broad range of cancers. This platform is based on decades-long research and development on unique properties of Virus specific T-cells (VSTs) by our Scientific Co-Founder, Dr. Malcolm Brenner, and his team at Baylor College of Medicine.

Tessa is proud to be innovators in the field of cancer immunotherapy and remain committed to making a difference in the lives of cancer patients worldwide. Our global headquarters are in Singapore, where we are building our own state-of-the-art commercial manufacturing facility. We are also currently setting up our United States headquarters in New Jersey.

tt-img-sab-malcolm-20201217

Malcolm K. Brenner,
M.D., Ph.D.

Scientific Co-Founder & Advisor

Our Leadership

Jeffrey H. Buchalter
President and Chief Executive Officer
Learn More >>
Ivan D. Horak, M.D.
EVP, Chief Medical Officer and Chief Scientific Officer
Learn More >>
David McIntyre
EVP, Chief Financial Officer
Learn More >>
John Ng
EVP, Chief Technical Officer
Learn More >>

Board of Directors

Dr. Göran Ando
Chairman
Learn More >>
Mr. Jeffrey H. Buchalter
President and Chief Executive Officer
Learn More >>
Dr. Fidah Alsagoff
Director
Learn More >>
Dr. George W. Sledge
Director
Learn More >>

Scientific Advisory Board

Malcolm K. Brenner, M.D., Ph.D.
Scientific Co-Founder & Scientific Advisor
Learn More >>
Giulio F. Draetta, M.D., Ph.D.
Head of Scientific Advisory Board
Learn More >>
Rafi Ahmed, Ph.D.
Scientific Advisor
Learn More >>
Tak W. Mak, Ph.D.
Scientific Advisor
Learn More >>
Waseem Qasim, M.D., Ph.D.
Scientific Advisor
Learn More >>
Pamela Ohashi, Ph.D.
Scientific Advisor
Learn More >>
Lillian L. Siu, M.D.
Scientific Advisor
Learn More >>
Filip Janku, M.D., Ph.D.
Scientific Advisor
Learn More >>
Aurélien Marabelle M.D., Ph.D.
Scientific Advisor
Learn More >>
Dmitriy Zamarin, M.D., Ph.D.
Scientific Advisor
Learn More >>
Anthony Chan Tak Cheung, M.D.
Scientific Advisor
Learn More >>
Mario Sznol, M.D.
Scientific Advisor
Learn More >>
Josep Tabernero, M.D., Ph.D.
Scientific Advisor
Learn More >>
Louis M. Weiner, M.D.
Scientific Advisor
Learn More >>
Ivan D. Horak, M.D.
Scientific Advisor
Learn More >>

Strategic Partners

Baylor College of Medicine
Learn More >>
University of North Carolina
Learn More >>
St. Jude Children’s Research Hospital
Learn More >>
National Cancer Centre Singapore
Learn More >>
Agency for Science, Technology and Research
Learn More >>